Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Colorcon
AddedFeb 17, 2024
UpdatedJun 28, 2026
Colorcon

Colorcon

Public

Colorcon, Inc.: Global leader in pharmaceutical products, offering excipients, food colorants, and more.

HQ
Harleysville, PA, US
Founded
1961
Overview
Compare
Employees
Website

Founded with a vision to innovate in the pharmaceutical industry, Colorcon, Inc. is a global leader in formulated products. The company specializes in providing excipients, controlled release systems, confectionery inks, polishes, food colorants, and nutritional coating products. With a strong commitment to quality and customer service, Colorcon serves a diverse range of clients worldwide, focusing on enhancing the performance and aesthetics of pharmaceutical and nutritional products.

Colorcon has established itself as a key player in the industry through strategic alliances and continuous innovation. Notable achievements include the development of advanced controlled release technologies and a broad portfolio of high-quality excipients. The company's impact is evident in its widespread adoption by pharmaceutical manufacturers globally, contributing significantly to the efficiency and effectiveness of drug delivery systems.

Colorcon - Quick Facts

When was Colorcon founded?

Colorcon was founded in 1961.

Where is Colorcon's headquarters located?

Colorcon's headquarters is located in Harleysville, PA, US.

How many employees does Colorcon have?

Colorcon has 350 employees as of Feb 10, 2024.

Colorcon - Classification

Industry
  • Hardware
Ownership
  • Public
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Excipients
  • Pharmaceutical Products
Tags
  • Pharmaceutical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2022Manufacture of paints, varnishes and similar coatings, printing ink and mastics
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 7210Research and experimental development on natural sciences and engineering
Show 22 more industry codes
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
  • 325910Printing Ink Manufacturing
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424600Chemical and Allied Products Merchant Wholesalers
  • 424690Other Chemical and Allied Products Merchant Wholesalers
  • 540000Professional, Scientific, and Technical Services
  • 420000Wholesale Trade
  • 541000Professional, Scientific, and Technical Services
  • 325900Other Chemical Product and Preparation Manufacturing
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2000Food And Kindred Products
  • 2890Miscellaneous Chemical Products
  • 2893Printing Ink
  • 5100Wholesale trade--nondurable goods
  • 5160Chemicals And Allied Products
  • 5169Chemicals And Allied Products, Not Elsewhere Classified
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research